Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)

Short-term glycemic variability is associated with the risk of hypoglycemia and hyperglycemia in people living with type 1 diabetes and can potentially affect clinical outcomes. Continuous glucose monitoring (CGM) is of increasing importance to evaluate glycemic variability in greater detail. Specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Mader, Julia K, Gölz, Stefan, Bilz, Stefan, Bramlage, Peter, Danne, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422797/
https://www.ncbi.nlm.nih.gov/pubmed/36007982
http://dx.doi.org/10.1136/bmjdrc-2022-002898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422797/
https://www.ncbi.nlm.nih.gov/pubmed/36007982
http://dx.doi.org/10.1136/bmjdrc-2022-002898

Ejemplares similares